Aydin, S. Z. Et Al. 2010. Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.5 , 752-755.

Aydin, S. Z., Can, M., Atagunduz, P., & Direskeneli, H., (2010). Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.5, 752-755.

Aydin, S. Et Al. "Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.5, 752-755, 2010

Aydin, S. Z. Et Al. "Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.5, pp.752-755, 2010

Aydin, S. Z. Et Al. (2010) . "Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.5, pp.752-755.

@article{article, author={S. Z. Aydin Et Al. }, title={Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2010, pages={752-755} }